Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02057107
Title Stereotactic Body Radiation Therapy (SBRT) With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

head and neck squamous cell carcinoma

Therapies

Cetuximab

Docetaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.